Appendix Material and Methods

Cloning of MCUR1 constructs
The sequences encoding MCUR1 (NP_001026883) residues 138-338 (MCUR1138-338) were amplified using polymerase chain reaction (PCR) from human oral squamous carcinoma YD-10B cDNA. For in vitro binding assays, MCUR1138-338 was cloned into a modified pET28a vector (Novagen) containing His6-maltose binding protein (MBP)-TEV.
Each sequence was also cloned into modified pET41a vector (Novagen) containing glutathione S-transferase (GST), which altered the thrombin site for a TEV protease site.
For mammalian cell expression, full-length MCUR1 was cloned into pCS2-MT vector, which also encodes an N-terminal 6 × myc. pCS2-MT vector was purchased from 21C
Frontier Human Gene Bank (Daejeon, Korea).
In vitro binding of MCU to MCUR1
His-or GST-fused MCU NTD and MCUR1 (residues, 138-338; MCUR1138-338) were purified using conventional Ni-NTA or GST affinity methods followed by SEC using a final buffer containing 20 mM Tris-HCl (pH 7.5), 100 mM NaCl, 0.5 mM EDTA, 0.5 mM EGTA, and 0.5 mM DTT. All reactive proteins were combined to final level of 0.25 mg per GST column pre-packed with 0.3 mL of GST beads. His-MCU NTD and GST-MCUR1138-338 or His-MBP-MCUR1138-338 and GST-MCU NTD with GST resin were incubated for 12 h on ice.
To visualize pull-down combinations, samples were subjected to 20% (w/v) SDS-PAGE and western blotting as described below. 
Cross-linking assay
To confirm the oligomerization of MCU NTD-E, cross-linking assay was performed using glutaraldehyde (GA) as a cross-linker. MCU NTD-E was prepared in phosphate- 
